Search

everythinglearnresearchcommunity

for

Search:↓

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

The Protein-Sparing Modified Fast is effective for rapid weight loss and maintaining it, but requires medical supervision and can have side effects.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

NAFLD in PCOS patients is linked to early kidney problems.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

PCOS may be influenced by factors in the blood, not just the ovaries.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

The case emphasizes the need for careful screening in children for insulin resistance and related conditions.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

There's no significant link between blood fat levels and male pattern baldness.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Premature hair greying may indicate a higher risk of metabolic problems.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.